Thanakorn Surarak, Supatat Chumnumwat, Wichit Nosoongnoen, & Pramote Tragulpiankit. (2024). Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review. Wiley.
Chicago Style (17th ed.) CitationThanakorn Surarak, Supatat Chumnumwat, Wichit Nosoongnoen, and Pramote Tragulpiankit. Efficacy, Safety, and Pharmacokinetics of Isoniazid Affected by NAT2 Polymorphisms in Patients with Tuberculosis: A Systematic Review. Wiley, 2024.
MLA (9th ed.) CitationThanakorn Surarak, et al. Efficacy, Safety, and Pharmacokinetics of Isoniazid Affected by NAT2 Polymorphisms in Patients with Tuberculosis: A Systematic Review. Wiley, 2024.
Warning: These citations may not always be 100% accurate.